z-logo
Premium
A randomized controlled trial of mindfulness‐based cognitive therapy for bipolar disorder
Author(s) -
Perich T.,
Manicavasagar V.,
Mitchell P. B.,
Ball J. R.,
HadziPavlovic D.
Publication year - 2013
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/acps.12033
Subject(s) - young mania rating scale , bipolar disorder , psychology , mania , anxiety , mindfulness , randomized controlled trial , mindfulness based cognitive therapy , mood , psychiatry , clinical psychology , rating scale , depression (economics) , cognitive therapy , cognition , medicine , developmental psychology , economics , macroeconomics
Objective To compare the efficacy of mindfulness‐based cognitive therapy ( MBCT ) plus treatment as usual ( TAU ) to TAU alone for patients with bipolar disorder over a 12‐month follow‐up period. Method Participants with a DSM ‐ IV diagnosis of bipolar disorder were randomly allocated to either MBCT plus TAU or TAU alone. Primary outcome measures were time to recurrence of a DSM ‐ IV major depressive, hypomanic or manic episode; the M ontgomery‐ Å sberg D epression R ating S cale ( MADRS ); and Y oung M ania R ating S cale ( YMRS ). Secondary outcome measures were number of recurrences, the D epression A nxiety S tress S cales ( DASS ), and the S tate T rait A nxiety I nventory ( STAI ). Results Ninety‐five participants with bipolar disorder were recruited to the study ( MBCT  = 48; TAU  = 47). Intention‐to‐treat ( ITT ) analysis found no significant differences between the groups on either time to first recurrence of a mood episode or total number of recurrences over the 12‐month period. Furthermore, there were no significant between‐group differences on the MADRS or YMRS scales. A significant between‐group difference was found in STAI – state anxiety scores. There was a significant treatment by time interaction for the DAS – achievement subscale. Conclusion While MBCT did not lead to significant reductions in time to depressive or hypo/manic relapse, total number of episodes, or mood symptom severity at 12‐month follow‐up, there was some evidence for an effect on anxiety symptoms. This finding suggests a potential role of MBCT in reducing anxiety comorbid with bipolar disorder.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom